State Street: MacroGenics MGNX Historial de posiciones en acciones
Comprado
Mantenidas
Vendido
| Trimestre | Valor de mercado | Estado | Acciones |
Cambio en la posición | Valor operado | Peso en el portafolio | Puesto en el portafolio | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | USD 4.51 M | Compra |
1,167,355
+303,692
| +35% | +USD 1.25 M | ﹤0.01% | 3100 |
|
|
2026
Q2 | USD 3.99 M | Compra |
863,663
+569,976
| +194% | +USD 2.16 M | ﹤0.01% | 3159 |
|
|
2026
Q1 | USD 849 k | Compra |
293,687
+19,100
| +7% | +USD 40.7 k | ﹤0.01% | 3520 |
|
|
2025
Q4 | USD 442 k | Sin cambios |
274,587
| – | – | ﹤0.01% | 3709 |
|
|
2025
Q3 | USD 461 k | Venta |
274,587
-25,700
| -9% | -USD 41.6 k | ﹤0.01% | 3676 |
|
|
2025
Q2 | USD 363 k | Venta |
300,287
-1,109,025
| -79% | -USD 1.61 M | ﹤0.01% | 3684 |
|
|
2025
Q1 | USD 1.79 M | Venta |
1,409,312
-53,220
| -4% | -USD 139 k | ﹤0.01% | 3286 |
|
|
2024
Q4 | USD 4.75 M | Compra |
1,462,532
+35,142
| +2% | +USD 127 k | ﹤0.01% | 3004 |
|
|
2024
Q3 | USD 4.7 M | Venta |
1,427,390
-115,200
| -7% | -USD 449 k | ﹤0.01% | 3001 |
|
|
2024
Q2 | USD 6.56 M | Venta |
1,542,590
-2,847,057
| -65% | -USD 27.7 M | ﹤0.01% | 2800 |
|
|
2024
Q1 | USD 64.6 M | Compra |
4,389,647
+2,215,625
| +102% | +USD 33.5 M | ﹤0.01% | 1582 |
|
|
2023
Q4 | USD 20.9 M | Compra |
2,174,022
+873,621
| +67% | +USD 6.04 M | ﹤0.01% | 2182 |
|
|
2023
Q3 | USD 6.06 M | Compra |
1,300,401
+100
| +0% | +USD 498 | ﹤0.01% | 2837 |
|
|
2023
Q2 | USD 6.96 M | Venta |
1,300,301
-2,965
| -0.2% | -USD 18.3 k | ﹤0.01% | 2833 |
|
|
2023
Q1 | USD 9.34 M | Compra |
1,303,266
+11,853
| +0.9% | +USD 71.4 k | ﹤0.01% | 2700 |
|
|
2022
Q4 | USD 8.67 M | Venta |
1,291,413
-85,891
| -6% | -USD 471 k | ﹤0.01% | 2789 |
|
|
2022
Q3 | USD 4.76 M | Compra |
1,377,304
+108,750
| +9% | +USD 416 k | ﹤0.01% | 3085 |
|
|
2022
Q2 | USD 3.74 M | Venta |
1,268,554
-2,276,170
| -64% | -USD 12 M | ﹤0.01% | 3242 |
|
|
2022
Q1 | USD 31.2 M | Compra |
3,544,724
+632,054
| +22% | +USD 6.98 M | ﹤0.01% | 2073 |
|
|
2021
Q4 | USD 46.7 M | Venta |
2,912,670
-30,111
| -1% | -USD 567 k | ﹤0.01% | 1852 |
|
|
2021
Q3 | USD 61.6 M | Venta |
2,942,781
-288,778
| -9% | -USD 6.96 M | ﹤0.01% | 1646 |
|
|
2021
Q2 | USD 86.8 M | Compra |
3,231,559
+562,389
| +21% | +USD 16.5 M | ﹤0.01% | 1416 |
|
|
2021
Q1 | USD 85 M | Compra |
2,669,170
+91,807
| +4% | +USD 2.23 M | ﹤0.01% | 1358 |
|
|
2020
Q4 | USD 58.9 M | Compra |
2,577,363
+267,695
| +12% | +USD 6.16 M | ﹤0.01% | 1540 |
|
|
2020
Q3 | USD 58.2 M | Compra |
2,309,668
+740,388
| +47% | +USD 20.2 M | ﹤0.01% | 1345 |
|
|
2020
Q2 | USD 43.8 M | Venta |
1,569,280
-346,568
| -18% | -USD 6.02 M | ﹤0.01% | 1540 |
|
|
2020
Q1 | USD 11.2 M | Venta |
1,915,848
-14,762
| -0.8% | -USD 134 k | ﹤0.01% | 2215 |
|
|
2019
Q4 | USD 21 M | Compra |
1,930,610
+43,992
| +2% | +USD 436 k | ﹤0.01% | 2103 |
|
|
2019
Q3 | USD 24.1 M | Venta |
1,886,618
-737,257
| -28% | -USD 10.6 M | ﹤0.01% | 1950 |
|
|
2019
Q2 | USD 44.5 M | Compra |
2,623,875
+1,200,157
| +84% | +USD 20.6 M | ﹤0.01% | 1558 |
|
|
2019
Q1 | USD 25.6 M | Compra |
1,423,718
+78,189
| +6% | +USD 1.35 M | ﹤0.01% | 1888 |
|
|
2018
Q4 | USD 17.1 M | Compra |
1,345,529
+106,414
| +9% | +USD 1.78 M | ﹤0.01% | 2100 |
|
|
2018
Q3 | USD 26.6 M | Venta |
1,239,115
-277,997
| -18% | -USD 5.93 M | ﹤0.01% | 1981 |
|
|
2018
Q2 | USD 31.3 M | Compra |
1,517,112
+476,510
| +46% | +USD 10.7 M | ﹤0.01% | 1823 |
|
|
2018
Q1 | USD 26.2 M | Venta |
1,040,602
-5,334
| -0.5% | -USD 130 k | ﹤0.01% | 1865 |
|
|
2017
Q4 | USD 19.9 M | Compra |
1,045,936
+41,719
| +4% | +USD 779 k | ﹤0.01% | 2049 |
|
|
2017
Q3 | USD 18.6 M | Compra |
1,004,217
+34,996
| +4% | +USD 606 k | ﹤0.01% | 2079 |
|
|
2017
Q2 | USD 17 M | Venta |
969,221
-37,990
| -4% | -USD 725 k | ﹤0.01% | 2110 |
|
|
2017
Q1 | USD 18.7 M | Compra |
1,007,211
+167,720
| +20% | +USD 3.24 M | ﹤0.01% | 1991 |
|
|
2016
Q4 | USD 17.2 M | Compra |
839,491
+8,661
| +1% | +USD 218 k | ﹤0.01% | 2012 |
|
|
2016
Q3 | USD 24.9 M | Compra |
830,830
+115,323
| +16% | +USD 3.43 M | ﹤0.01% | 1633 |
|
|
2016
Q2 | USD 19.3 M | Venta |
715,507
-94,198
| -12% | -USD 2.12 M | ﹤0.01% | 1781 |
|
|
2016
Q1 | USD 15.2 M | Compra |
809,705
+33,309
| +4% | +USD 634 k | ﹤0.01% | 1914 |
|
|
2015
Q4 | USD 24 M | Venta |
776,396
-681,213
| -47% | -USD 20.7 M | ﹤0.01% | 1588 |
|
|
2015
Q3 | USD 31.2 M | Compra |
1,457,609
+255,280
| +21% | +USD 8.01 M | ﹤0.01% | 1442 |
|
|
2015
Q2 | USD 45.7 M | Compra |
1,202,329
+234,963
| +24% | +USD 7.72 M | ﹤0.01% | 1325 |
|
|
2015
Q1 | USD 30.3 M | Compra |
967,366
+658,657
| +213% | +USD 22.3 M | ﹤0.01% | 1542 |
|
|
2014
Q4 | USD 10.8 M | Compra |
308,709
+29,503
| +11% | +USD 735 k | ﹤0.01% | 2178 |
|
|
2014
Q3 | USD 5.84 M | Venta |
279,206
-2,916
| -1% | -USD 60.3 k | ﹤0.01% | 2465 |
|
|
2014
Q2 | USD 6.13 M | Compra |
282,122
+186,373
| +195% | +USD 3.92 M | ﹤0.01% | 2475 |
|
|
2014
Q1 | USD 2.66 M | Compra |
95,749
+17,837
| +23% | +USD 630 k | ﹤0.01% | 2925 |
|
|
2013
Q4 | USD 2.14 M | Compra |
+77,912
| Nuevas | +USD 2.04 M | ﹤0.01% | 3037 |
|
Otros fondos que tienen MGNX en su portafolio
Posición de State Street en MGNX: resumen de T3 2026
State Street aumentó su participación en MacroGenics (MGNX) en 35% durante T3 2026, al comprar aproximadamente USD 1.25 M y elevar la posición a 1,167,355 acciones con un valor de USD 4.51 M. La posición representa ﹤0.01% del portafolio y ocupa el puesto #3100.
State Street reportó por primera vez una posición en MGNX en T4 2013 y desde entonces la ha mantenido en 52 trimestres. La posición alcanzó su máximo de USD 86.8 M en T2 2021. Al cierre de T3 2026, 131 fondos que sigue Wall St. Rank mantienen una posición en MGNX.
- Al cierre de T3 2026, State Street tenía 1,167,355 acciones de MacroGenics con un valor de USD 4.51 M.
- State Street compró 303,692 acciones de MacroGenics en T3 2026, por un monto estimado de USD 1.25 M.
- MacroGenics representó el ﹤0.01% del portafolio de State Street en T3 2026 y fue su posición número 3100.
- State Street reportó por primera vez una posición en MacroGenics en T4 2013 y desde entonces la ha mantenido en 52 trimestres.
- La posición de State Street en MacroGenics alcanzó su máximo de USD 86.8 M en T2 2021.
- Al cierre de T3 2026, 131 fondos que sigue Wall St. Rank tenían MacroGenics en su portafolio.
Según el informe 13F de State Street correspondiente a T3 2026, presentado el 12 nov 2026.